Produktbild: Hypertension

Hypertension A Companion to Braunwald's Heart Disease

168,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

25.01.2024

Herausgeber

Bakris George L. + weitere

Verlag

Elsevier

Seitenzahl

640

Maße (L/B/H)

28,2/22/2,8 cm

Gewicht

1580 g

Auflage

4th edition

Sprache

Englisch

ISBN

978-0-323-88369-6

Beschreibung

Portrait

George L Bakris, MD, is a nephrologist whose specialty is kidney function/disease and hypertension. He has led several large NIH-funded studies resulting in paradigm shifts in blood pressure treatment guidelines for patients with treatable and challenging hypertension. Dr Bakris is Professor of Medicine and Director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago in Chicago, Illinois.

Matthew J Sorrentino, MD, a cardiologist whose focus is preventive cardiology, is Professor of Medicine at the Bucksbaum Institute for Clinical Excellence and Vice Chair of Clinical Operations for the Department of Medicine at the University of Chicago. Both Drs Bakris and Sorrentino edited the current edition of Hypertension.

Luke J Laffin, MD, is Co-Director of the Center for Blood Pressure Disorders in the Department of Cardiovascular Medicine at Cleveland Clinic in Cleveland, Ohio. Dr Laffin was a contributor on the current edition.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

25.01.2024

Herausgeber

Verlag

Elsevier

Seitenzahl

640

Maße (L/B/H)

28,2/22/2,8 cm

Gewicht

1580 g

Auflage

4th edition

Sprache

Englisch

ISBN

978-0-323-88369-6

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Hypertension
  • SECTION I: EPIDEMIOLOGY AND PREVENTIVE STRATEGIES
    1. General Population and Global Cardiovascular Risk Prediction
    2. Diet and Hypertension
    3. Exercise and Hypertension
    4. Hypertension in Women

    SECTION II: PATHOPHYSIOLOGY
    5. Pathophysiology of Hypertension
    6. Genetics of Hypertension
    7. Inflammation and Immunity in Hypertension

    SECTION III: DIAGNOSIS AND EVALUATION
    8. The Environment and High Blood Pressure
    9. Office Blood Pressure Measurement
    10. Home Monitoring of Blood Pressure
    11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
    12. White Coat and Masked Hypertension
    13. Renovascular Hypertension and ISchemic Neuropathy
    14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
    15. Secondary Hypertension: Pheochromocytoma and Paraganglioma
    16. Sleep Disruption and Blood Pressure

    SECTION IV: RISK STRATIFICATION
    17. The Natural History of Untreated Hypertension
    18. Isolated Systolic Hypertension
    19. Assessment of Hypertension-Mediated Organ Damage

    SECTION V: ANTIHYPERTENSIVE THERAPY
    20. Diuretics Therapy
    21. Calcium Channel Blockers
    22. Renin Angiotensin Aldosterone System Blockers
    23. Aldosterone and Hypertension
    24. ß-Blockers, Central Sympathetic Agents,and Direct Vasodilators
    25. Peripheral Alpha Blockers
    26. Initial Combination Therapies
    27. Devices Therapies for Hypertension
    28. The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle

    SECTION VI: HYPERTENSION MANAGEMENT APPROACHES
    29. Approach to Difficult to Manage Primary Hypertension
    30. Team-Based Care for Hypertension Management
    31. Medication Adherence: Focus on Improvement
    32. Digital Health and Telemedicine for Hypertension

    SECTION VII HYPERTENSION MANAGEMENT WITH COMORBIDITIES
    33. Ischemic Heart Disease
    34. Heart Failure
    35. Hypertension and Chronic Kidney Disease Including Dialysis
    36. Transplant Hypertension
    37. Obesity and Hypertension: Pathophysiology and Treatment
    38. Cerebrovascular Disease
    39. Diabetes Mellitus: Management of Hypertension in Diabetes
    40. Onco-Hypertension: Anticancer Therapy-Associated Hypertension
    41. Autonomic Dysfunction and Orthostatic Hypotension
    42. Dyslipidemia
    43. Aorta and Peripheral Arterial Disease in Hypertension

    SECTION VIII SPECIAL POPULATIONS
    44. Hypertension in Pregnancy
    45. Hypertension in Older People
    46. Hypertension in African Americans
    47. Resistant Hypertension
    48. Hypertensive Emergencies and Urgencies
    49. Hypertension in Children: Diagnosis and Treatment

    Appendix Meta-Analyses of Blood Pressure Lowering Trials